Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-20-018621)

Filing Details

Accession Number:: 0001140361-20-018621
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-17 20:13:16
Reporting Period:: 2020-08-13

Accepted Time:: 2020-08-17 20:13:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1270073	Intercept Pharmaceuticals Inc.	ICPT	Pharmaceutical Preparations (2834)	223868459

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1559515	S.p.a. Genextra	Via G. De Grassi, 11 Milan L6 20123		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Disposition	2020-08-13	83,000	$52.60	5,417,000	No	4	S	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2020-08-14	54,600	$50.55	5,362,400	No	4	S	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2020-08-17	126,888	$50.15	5,235,512	No	4	S	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2020-08-17	1,235,512	$46.75	4,000,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Genextra S.p.A. will apply the proceeds from the sales to pay off outstanding indebtedness under its margin loan secured by its shares of Intercept's common stock, and for general corporate purposes.